Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | FDPS | P14324 | 10/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.44 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11370224 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL55151 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL2833675 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL16180459 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL16970225 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL16970217 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL16969980 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL16969619 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL665460 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 | |
| SCHEMBL16969776 | 1.00 | TSHR (0.50) | TSHRTHRBALDH1A1FDPSSMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751718-A | Dialkoxy magnesium carrier type solid catalyst component for ethylene polymerization or copolymerization, preparation method and application thereof | 任丘市利和科技发展有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-117138836-A | Oxide/iodine composite particles and dispersion of oxide/iodine composite particles | 中国石油化工股份有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-109134716-B | Vanadium catalyst and method for preparing olefin polymer | 北京引发科技有限公司 | 2020-11-10 | — | — | CN | claimed |
| CN-101921213-A | Method for synthesizing ketazine by hydrogen peroxide oxidation method | LIMING RES INST CHEMICAL IND | 2010-12-22 | — | — | CN | claimed |
| CN-1995084-A | Organic polymer graft modified nanometer titanium dioxide preparation method | UNIV ELECTRONIC SCIENCE & TECH (CN) | 2007-07-11 | — | — | CN | claimed |
| CN-1594495-A | Method for improving photoluminescence of nano anatase TiO#-[2] | UNIV ELECTRONIC SCIENCE & TECH (CN) | 2005-03-16 | — | — | CN | claimed |
| EP-0959138-B1 | Process for the preparation of Baccatin-III by enzymatic synthesis | INST BIOANALYTIK UMWELT TOXILO (DE) | 2004-09-29 | — | — | EP | claimed |
| US-4540744-A | LEWIS BASE, BUTYLLITHIUM, COUPLING WITH TIN, VULCANIZING | BRIDGESTONE TIRE COMPANY LIMITED (JP) | 1985-09-10 | — | — | US | claimed |
| CN-119751718-A | Dialkoxy magnesium carrier type solid catalyst component for ethylene polymerization or copolymerization, preparation method and application thereof | 任丘市利和科技发展有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20240172553-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2024-05-23 | — | — | US | disclosed |
| US-11957051-B2 | Organic semiconductor mixture and organic optoelectronic device containing the same | Raynergy Tek Incorporation (TW) | 2024-04-09 | — | — | US | disclosed |
| US-20240099135-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2024-03-21 | — | — | US | disclosed |
| EP-4332096-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2024-03-06 | — | — | EP | disclosed |
| WO-2024011218-A1 | POLYMERIC NANOPARTICLES FOR LONG ACTING DELIVERY OF A PEPTIDE AND METHODS OF MAKING AND USING THEREOF | BROWN UNIVERSITY (US) | 2024-01-11 | — | — | WO | disclosed |
| US-4015976-A | N-acetyl L-polychlorobenzamide herbicides | TEXACO DEVELOPMENT CORPORATION (US) | 1977-04-05 | — | — | US | disclosed |
| US-4001214-A | AMINOALKYL ETHERS OF 2,2'- AND 3,3'-DIHYDROXYBENZIL | AMERICAN HOME PRODUCTS CORPORATION (US) | 1977-01-04 | — | — | US | disclosed |
| US-3959370-A | HERBICIDE | JEFFERSON CHEMICAL COMPANY, INC. (US) | 1976-05-25 | — | — | US | disclosed |
| US-3957803-A | CERTAIN TRANSIENT PRO-DRUG FORMS OF PHENYLBUTAZONE | INTERX RESEARCH CORPORATION (US) | 1976-05-18 | — | — | US | disclosed |
| US-3956101-A | HIGH GRADE NEEDLES, BUBBLING NON-OXIDIZING GAS THROUGH REFORMED OIL | KUREHA KAGAKU KOGYO KABUSHIKI KAISHA (JA) | 1976-05-11 | — | — | US | disclosed |
| US-3947404-A | CARDIAC THERAPY | BOEHRINGER MANNHEIM GMBH (DT) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240099135-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT | ARNT, NR2E3, CRY1 | TSHR 1656/4885THRB 1076/4885ALDH1A1 129/4885 |
| US-20240172553-A1 | ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT | NOM1, L1CAM, AP2M1 | TSHR 4074/4885THRB 3866/4885ALDH1A1 394/4885 |
| US-11957051-B2 | Organic semiconductor mixture and organic optoelectronic device containing the same | OSTC, NONO, OR10J3 | TSHR 3880/4885THRB 2951/4885ALDH1A1 3861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.